draglet Offers Its Industry Standard Cryptocurrency Exchange & ICO Platform Source Code for Sale to the Public
draglet GmbH, a leading blockchain development company, is offering its proprietary exchange and ICO platform source code for outright purchase. This makes draglet the first exchange development company to make its source code available for sale to operators of cryptocurrency exchanges or companies launching an ICO. Competitors in the space keep their source code hidden from customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180503006059/en/
draglet is offering its proprietary exchange and ICO platform source code for outright purchase. (Graphic: Business Wire)
“We felt there were a lot of unreliable scripts on the marketplace. None of them offered the enterprise-level security and scalability that our script offers our customers,” said Peter Kohlschmidt, Managing Director at draglet. “By offering our exchange script for sale, we’ll reach a wider audience and create an industry standard for software behind cryptocurrency exchanges and ICOs.”
draglet’s exchange and ICO source code has been available for purchase on draglet’s website in pre-launch alpha since late April. Customer interest and feedback from previous clients has been positive, indicating strong interest in source code for purchase.
draglet Exchange Architecture
The industry-leading exchange and ICO software is designed for speed, security, and overall usability. The flexible architecture of the draglet software allows customers to build their own applications atop the existing code. In fact, the same source code powers both white label cryptocurrency exchanges and ICO crowdsales with minimal modification. Features and functionality can be customized to the user’s liking.
The code is structured into five different modules. Each is independent of the other modules, but all modules communicate with one another. In addition to these five core modules, customers who purchase the source code can add their own features and services as well. In the near future, draglet will offer optional add-on services that allow customers to purchase additional features as-needed.
Creating an Industry Standard
draglet aims to create a new industry standard for cryptocurrency exchange. The new business model revolves around not just selling world-class software, but also providing the training, specifications, certifications, and support necessary to create industry-wide adoption. This new initiative positions draglet as a global leader in creating, operating, training, and supporting global cryptocurrency exchange.
As a result, draglet customers can now expect an all-around solution for implementing a new exchange or ICO. Business concerns like accounting/compliance, technical software/hardware implementation, and training on exchange administration/management are part of the complete package.
For more information about draglet’s software source code, please visit: https://www.draglet.com
About draglet GmbH
draglet is a German company founded in 2013, specializing in developing blockchain applications and bitcoin/cryptocurrency exchange software for businesses. Based in Munich, Bavaria, draglet has been an early leader in blockchain services and smart contracts. With its renowned custom, white-label exchange software, draglet has set new standards in the cryptocurrency market. draglet solutions are in use in over 20 countries worldwide.
Contact: Stefan Chun Yin
Phone: +49 151 466 388 68
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection19.11.2018 03:00 | Pressemelding
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg). Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300 mg but at one-tenth of the dose. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it can be given at a lower dose, resulting in less tenofovir in the bloodstream. In clinical trials, Vemlidy demonstrated improved renal and bone laboratory safety parameters compared to Viread. “With the approval of Vemlidy, physicians can now offer their patients a treatment that retains the efficacy of TDF while improving renal and bone safety parameters in cli
Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems19.11.2018 00:01 | Pressemelding
Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer healthcare providers and patients greater treatment choice and value, better access to treatments and improved patient outcomes. According to data provided by IMS Health, biosimilars could lead to cumulative savings of up to 107 billion USD by 2020 in the United States (US) and the top five European Union (EU) countries.1 The EU has made significant progress in unlocking the potential of biosimilars through continuous education of providers, payers and patients. This has been critical to EU biosimilar acceptance but has not been seen in the US, which has lagged behind. During a presentation on the opportunities and challenges presented by the use of biosimilars in the US, Celltrion Healthcare highlighted several challenges affecting the uptake of biosimilars within the US market. Both physicians an
Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 13:40 | Pressemelding
Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an
Philip Morris International and Dorna Switch Gears in Quest for a World without Tobacco Smoke17.11.2018 11:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE:PM) and Dorna Sports S.L., the commercial rights holder for the world FIM MotoGP Championships, have extended their partnership until the end of 2021. The two organizations have collaborated successfully for 26 years. As of 2019, the partnership will focus on advancing the cause of a smoke-free world. More than 1 billion people smoke today and, according to the World Health Organization, will continue to smoke in the near future. PMI has committed to transform its business and encourage all men and women who would otherwise continue smoking to replace cigarettes with better alternatives as soon as possible. With around 350 million MotoGP fans worldwide, MotoGP can play a significant role in positively impacting the lives of people who smoke and those around them. “The best choice for consumers concerned about the health risks of smoking is to quit tobacco and nicotine altogether. Today, however, technology, science and innovation provide a r
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 18:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33 | Pressemelding
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W